Latest News & Features
Americas
Teva will appeal against a decision which saw the invalidation of four patents covering its multiple sclerosis drug Copaxone. 31 January 2017
Americas
Mylan's plans to bring a generic version of Shire's bowel disease drug Lialda to market were shut down when a district court judge held that the action would infringe Shire's patent. 30 January 2017
Big Pharma
The University of Oxford and Denmark-based Novo Nordisk have entered into a DKr1 billion ($143 million) research collaboration focusing on type 2 diabetes. 30 January 2017
Americas
A number of doctors have filed amicus briefs backing Sanofi and Regeneron in their fight against an injunction obtained by Amgen. 27 January 2017
Americas
The US Court of Appeals for the Federal Circuit affirmed a ruling of a district court yesterday, agreeing that Mylan infringed Cumberland Pharmaceuticals’ patent for Acetadote. 27 January 2017
Europe
The European Commission has given Abbott Laboratories the green light to acquire diagnostic test maker Alere. 26 January 2017
Africa
Global intellectual property strategy will be the chief area of focus for IP counsel in the life sciences arena in 2017. 26 January 2017
Americas
US-based drugs company Aralez Pharmaceuticals has filed a patent infringement complaint against Teva centring on the drug Yosprala, a delayed-release aspirin. 25 January 2017
Americas
The US Court of Appeals for the Federal Circuit has vacated a district court’s grant of summary judgment of non-infringement and remanded a case involving China-based Zhejiang Medicine, Japanese company Keneka and ZMC-USA. 25 January 2017
Americas
Endo Pharmaceuticals yesterday settled charges brought by the Federal Trade Commission by abandoning anti-competitive pay-for-delay agreements. 24 January 2017